1. Academic Validation
  2. In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents

In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents

  • Antimicrob Agents Chemother. 1988 Jan;32(1):150-2. doi: 10.1128/AAC.32.1.150.
A L Barry 1
Affiliations

Affiliation

  • 1 Clinical Microbiology Institute, Tualatin, Oregon 97062.
Abstract

DuP 105 and DuP 721 are two members of the oxazolidinones, a new class of synthetic antimicrobial agents with activity against gram-positive bacteria. In vitro tests compared the two new drugs with five other antimicrobial agents against 216 gram-positive isolates representing 4 genera and 10 species. DuP 721 MICs for 50% of the strains tested (MIC50s) ranged from 2.0 to 8.0 micrograms/ml, DuP 105 MIC50S ranged from 4.0 to 16 micrograms/ml, and vancomycin MIC50S ranged from 0.25 to 1.0 microgram/ml. Methicillin-resistant and -susceptible staphylococci were susceptible to ciprofloxacin, vancomycin, and DuP 721.

Figures
Products